Clinical Trial Detail

NCT ID NCT04037462
Title Induction of Sensecence Using Dexamethasone to Re-sensitize NSCLC to Anti-PD1 Therapy
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors VA Office of Research and Development
Indications

lung non-small cell carcinoma

Therapies

Dexamethasone

Age Groups: adult senior

No variant requirements are available.